Bopindolol (INN) is an ester prodrug for the beta blocker pindolol.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | Bopindolol may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Bopindolol may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Bopindolol. |
| Amiodarone | The therapeutic efficacy of Bopindolol can be increased when used in combination with Amiodarone. |
| Bupivacaine | The serum concentration of Bupivacaine can be increased when it is combined with Bopindolol. |
| Dipyridamole | Dipyridamole may increase the bradycardic activities of Bopindolol. |
| Disopyramide | Disopyramide may increase the bradycardic activities of Bopindolol. |
| Dronedarone | Dronedarone may increase the bradycardic activities of Bopindolol. |
| Fingolimod | Bopindolol may increase the bradycardic activities of Fingolimod. |
| Floctafenine | The risk or severity of adverse effects can be increased when Bopindolol is combined with Floctafenine. |
| Mepivacaine | The serum concentration of Mepivacaine can be increased when it is combined with Bopindolol. |
| Methacholine | Bopindolol may increase the bronchoconstrictory activities of Methacholine. |
| Midodrine | The therapeutic efficacy of Midodrine can be decreased when used in combination with Bopindolol. |
| Nifedipine | The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Bopindolol. |
| Propafenone | The risk or severity of adverse effects can be increased when Propafenone is combined with Bopindolol. |
| Regorafenib | Regorafenib may increase the bradycardic activities of Bopindolol. |
| Reserpine | Reserpine may increase the hypotensive activities of Bopindolol. |
| Deserpidine | Deserpidine may increase the hypotensive activities of Bopindolol. |
| Guanethidine | Guanethidine may increase the hypotensive activities of Bopindolol. |
| Rivastigmine | Bopindolol may increase the bradycardic activities of Rivastigmine. |
| Mirabegron | The serum concentration of Bopindolol can be increased when it is combined with Mirabegron. |
| Insulin argine | Bopindolol may increase the hypoglycemic activities of Insulin argine. |
| Nicotine | The risk or severity of adverse effects can be increased when Bopindolol is combined with Nicotine. |
| Cevimeline | The risk or severity of adverse effects can be increased when Bopindolol is combined with Cevimeline. |
| Carbamoylcholine | The risk or severity of adverse effects can be increased when Bopindolol is combined with Carbamoylcholine. |
| Bethanechol | The risk or severity of adverse effects can be increased when Bopindolol is combined with Bethanechol. |
| Pilocarpine | The risk or severity of adverse effects can be increased when Bopindolol is combined with Pilocarpine. |
| Varenicline | The risk or severity of adverse effects can be increased when Bopindolol is combined with Varenicline. |
| Acetylcholine | The risk or severity of adverse effects can be increased when Bopindolol is combined with Acetylcholine. |
| Arecoline | The risk or severity of adverse effects can be increased when Bopindolol is combined with Arecoline. |
| Lobeline | The risk or severity of adverse effects can be increased when Bopindolol is combined with Lobeline. |
| NGX267 | The risk or severity of adverse effects can be increased when Bopindolol is combined with NGX267. |
| GTS-21 | The risk or severity of adverse effects can be increased when Bopindolol is combined with GTS-21. |
| Epibatidine | The risk or severity of adverse effects can be increased when Bopindolol is combined with Epibatidine. |
| Xanomeline | The risk or severity of adverse effects can be increased when Bopindolol is combined with Xanomeline. |
| Thiethylperazine | The serum concentration of Bopindolol can be increased when it is combined with Thiethylperazine. |
| Promazine | The serum concentration of Bopindolol can be increased when it is combined with Promazine. |
| Prochlorperazine | The serum concentration of Bopindolol can be increased when it is combined with Prochlorperazine. |
| Triflupromazine | The serum concentration of Bopindolol can be increased when it is combined with Triflupromazine. |
| Fluphenazine | The serum concentration of Bopindolol can be increased when it is combined with Fluphenazine. |
| Moricizine | The serum concentration of Bopindolol can be increased when it is combined with Moricizine. |
| Trifluoperazine | The serum concentration of Bopindolol can be increased when it is combined with Trifluoperazine. |
| Perphenazine | The serum concentration of Bopindolol can be increased when it is combined with Perphenazine. |
| Mesoridazine | The serum concentration of Bopindolol can be increased when it is combined with Mesoridazine. |
| Acetophenazine | The serum concentration of Bopindolol can be increased when it is combined with Acetophenazine. |
| Promethazine | The serum concentration of Bopindolol can be increased when it is combined with Promethazine. |
| Alimemazine | The serum concentration of Bopindolol can be increased when it is combined with Alimemazine. |
| Periciazine | The serum concentration of Bopindolol can be increased when it is combined with Periciazine. |
| Acepromazine | The serum concentration of Bopindolol can be increased when it is combined with Acepromazine. |
| Aceprometazine | The serum concentration of Bopindolol can be increased when it is combined with Aceprometazine. |
| Pipotiazine | The serum concentration of Bopindolol can be increased when it is combined with Pipotiazine. |
| Thioproperazine | The serum concentration of Bopindolol can be increased when it is combined with Thioproperazine. |
| BL-1020 | The serum concentration of Bopindolol can be increased when it is combined with BL-1020. |
| Cyamemazine | The serum concentration of Bopindolol can be increased when it is combined with Cyamemazine. |
| Methylene blue | The serum concentration of Bopindolol can be increased when it is combined with Methylene blue. |
| Propiopromazine | The serum concentration of Bopindolol can be increased when it is combined with Propiopromazine. |
| Perazine | The serum concentration of Bopindolol can be increased when it is combined with Perazine. |
| Butaperazine | The serum concentration of Bopindolol can be increased when it is combined with Butaperazine. |
| Chlorproethazine | The serum concentration of Bopindolol can be increased when it is combined with Chlorproethazine. |
| Thiazinam | The serum concentration of Bopindolol can be increased when it is combined with Thiazinam. |
| Dixyrazine | The serum concentration of Bopindolol can be increased when it is combined with Dixyrazine. |
| Perphenazine enanthate | The serum concentration of Bopindolol can be increased when it is combined with Perphenazine enanthate. |
| Digoxin | Bopindolol may increase the bradycardic activities of Digoxin. |
| Acetyldigitoxin | Bopindolol may increase the bradycardic activities of Acetyldigitoxin. |
| Deslanoside | Bopindolol may increase the bradycardic activities of Deslanoside. |
| Ouabain | Bopindolol may increase the bradycardic activities of Ouabain. |
| Digitoxin | Bopindolol may increase the bradycardic activities of Digitoxin. |
| Oleandrin | Bopindolol may increase the bradycardic activities of Oleandrin. |
| Cymarin | Bopindolol may increase the bradycardic activities of Cymarin. |
| Proscillaridin | Bopindolol may increase the bradycardic activities of Proscillaridin. |
| Metildigoxin | Bopindolol may increase the bradycardic activities of Metildigoxin. |
| Lanatoside C | Bopindolol may increase the bradycardic activities of Lanatoside C. |
| Gitoformate | Bopindolol may increase the bradycardic activities of Gitoformate. |
| Acetyldigoxin | Bopindolol may increase the bradycardic activities of Acetyldigoxin. |
| Peruvoside | Bopindolol may increase the bradycardic activities of Peruvoside. |
| Lidocaine | The serum concentration of Lidocaine can be increased when it is combined with Bopindolol. |
| Icosapent | Icosapent may decrease the antihypertensive activities of Bopindolol. |
| Mesalazine | The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Bopindolol. |
| Indomethacin | Indomethacin may decrease the antihypertensive activities of Bopindolol. |
| Nabumetone | Nabumetone may decrease the antihypertensive activities of Bopindolol. |
| Ketorolac | Ketorolac may decrease the antihypertensive activities of Bopindolol. |
| Tenoxicam | Tenoxicam may decrease the antihypertensive activities of Bopindolol. |
| Celecoxib | Celecoxib may decrease the antihypertensive activities of Bopindolol. |
| Tolmetin | Tolmetin may decrease the antihypertensive activities of Bopindolol. |
| Rofecoxib | Rofecoxib may decrease the antihypertensive activities of Bopindolol. |
| Piroxicam | Piroxicam may decrease the antihypertensive activities of Bopindolol. |
| Fenoprofen | Fenoprofen may decrease the antihypertensive activities of Bopindolol. |
| Valdecoxib | Valdecoxib may decrease the antihypertensive activities of Bopindolol. |
| Diclofenac | Diclofenac may decrease the antihypertensive activities of Bopindolol. |
| Sulindac | Sulindac may decrease the antihypertensive activities of Bopindolol. |
| Flurbiprofen | Flurbiprofen may decrease the antihypertensive activities of Bopindolol. |
| Etodolac | Etodolac may decrease the antihypertensive activities of Bopindolol. |
| Mefenamic acid | Mefenamic acid may decrease the antihypertensive activities of Bopindolol. |
| Naproxen | Naproxen may decrease the antihypertensive activities of Bopindolol. |
| Sulfasalazine | Sulfasalazine may decrease the antihypertensive activities of Bopindolol. |
| Phenylbutazone | Phenylbutazone may decrease the antihypertensive activities of Bopindolol. |
| Meloxicam | Meloxicam may decrease the antihypertensive activities of Bopindolol. |
| Carprofen | Carprofen may decrease the antihypertensive activities of Bopindolol. |
| Diflunisal | Diflunisal may decrease the antihypertensive activities of Bopindolol. |
| Salicylic acid | Salicylic acid may decrease the antihypertensive activities of Bopindolol. |